$34.86
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition
Update: Harmony Biosciences Shares Fall After CFO Glenn Reicin Steps Down
Overview
52-week range
$26
$41
61% of range
Avg surprise (last 3)
-2.7%
Avg reaction (last 2)
+1.4%
50% positive
Latest IV / EM
75%
EM ±17.2% · $35 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $0.55 | $0.76 | -27.6% | -29.5% | -4.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.87 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.68 | $0.78 | -12.8% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.78 | $0.59 | +32.2% | — | +7.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.79 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.67 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.63 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.56 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | $0.87 | $0.68 | +27.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $215M | — | $239M | $200M | $185M | — | $186M | $173M |
| Cost of revenue | $45M | — | $60M | $38M | $32M | — | $43M | $32M |
| Gross profit | $171M | — | $180M | $162M | $153M | — | $143M | $141M |
| Operating income | $37M | — | $65M | $48M | $56M | — | $62M | $21M |
| Net income | $32M | — | $51M | $40M | $46M | — | $46M | $12M |
| EPS (diluted) | $0.55 | — | $0.87 | $0.68 | $0.78 | — | $0.79 | $0.20 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $589M | $753M | $647M | $546M | $489M | $453M | $387M | $317M |
| Inventory | $5M | $5M | $7M | $6M | $6M | $7M | $7M | $6M |
| Total current assets | $779M | $907M | $839M | $691M | $643M | $579M | $522M | $458M |
| Total assets | $1.27B | $1.27B | $1.21B | $1.11B | $1.06B | $999M | $928M | $858M |
| Long-term debt | $139M | $144M | $149M | $153M | $158M | $163M | $168M | $171M |
| Total liabilities | $361M | $401M | $373M | $335M | $335M | $340M | $331M | $320M |
| Total equity | $910M | $870M | $835M | $773M | $721M | $659M | $597M | $539M |